Taking ONC201 as an example, as a dopamine receptor D2 (DRD2) antagonist, it inactivates protein kinase B/extracellular-regulated protein kinases (AKT/ERK) signaling in tumor cells [118]. This evidence concerns the gene AKT1 and neoplasm.